-+ 0.00%
-+ 0.00%
-+ 0.00%
Is Lam Research (LRCX) Fairly Valued On Its $3b R And D Expansion Plan?
Share
Listen to the news

Lam Research (LRCX) is back in focus after announcing a plan to invest more than US$3b over five years to expand its global R&D lab network and increase experiment capacity by over 50%.

See our latest analysis for Lam Research.

Over the past year Lam Research has seen strong momentum, with a year to date share price return of 70.03% and a 1 year total shareholder return of 205.32%. However, the 7 day share price return declined 4.04% after recent sector pressure and profit taking.

If you are looking beyond Lam Research and want to see what else is moving as AI reshapes chip demand, this is a good moment to uncover 55 AI infrastructure stocks

After a 70% year to date surge and a recent pullback, Lam Research now trades about 18% below the average analyst price target but at a large premium to some fair value estimates. Is the market’s caution misplaced?

Most Popular Narrative: 2.7% Undervalued

On the most followed narrative, Lam Research is assessed at a fair value of $323.38 versus a last close of $314.66. This frames the current pullback as relatively modest against that estimate.

Expanding government incentives and a global push for semiconductor self-sufficiency (e.g., US and EU CHIPS Acts) are spurring new fab construction and regional equipment investments. This directly contributes to higher system sales and broadens Lam's customer base, reducing revenue cyclicality and regional risk.

Read the complete narrative.

Want to understand why this narrative still sees upside after a big share price run. The story leans on aggressive revenue expansion and richer margins anchored by premium earnings multiples. Curious which growth and profitability paths need to hold together to support that fair value label.

Result: Fair Value of $323.38 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, Lam Research still faces meaningful risks, particularly around export restrictions that could affect its China revenue and its concentrated exposure to a few large chipmakers.

Find out about the key risks to this Lam Research narrative.

Another View on Lam Research Valuation

While the most followed Lam Research narrative points to a small 2.7% undervaluation, the current P/E of 54.2x tells a different story. That is higher than the US Semiconductor industry at 45.1x, peers at 46.4x, and even the fair ratio of 46.9x. Is this a quality premium or a valuation risk building up?

For a closer look at what this rich earnings multiple might imply over time, including how it compares across industry peers and that fair ratio the market could move towards, See what the numbers say about this price — find out in our valuation breakdown.

NasdaqGS:LRCX P/E Ratio as at Aug 2026
NasdaqGS:LRCX P/E Ratio as at Aug 2026

Next Steps

If the mixed signals on Lam Research leave you unsure, this is the moment to move quickly and check the full picture for yourself. To see both the key upsides investors are watching and the main concerns they are flagging, start with these 2 key rewards and 2 important warning signs

Looking for more investment ideas beyond Lam Research?

LRCX might be on your radar already, but you do not want to miss other opportunities that could round out your portfolio and sharpen your next moves.

  • Spot potential mispricings early and scan through 49 high quality undervalued stocks that pair strong fundamentals with prices that may not fully reflect their underlying business strength.
  • Strengthen your income stream and review 12 dividend fortresses that combine higher yields with characteristics that may support more consistent shareholder payouts.
  • Prioritize resilience and investigate 74 resilient stocks with low risk scores that aim to keep volatility in check while still offering meaningful exposure to equities.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending